This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
AppFolio (APPF) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
AppFolio's (APPF) third-quarter results are expected to benefit from higher property manager units and growing number of property manager customers.
Will Herbalife (HLF) Q3 Earnings Grow Amid Currency Hurdles?
by Zacks Equity Research
Herbalife (HLF) is likely to gain from efforts that support direct selling, solid volumes and seed-to-feed strategy. However, unfavorable currency movements are expected to play spoilsport.
Herbalife (HLF) Q3 Earnings Preview: What to Know Ahead of the Release
by Zacks Equity Research
Herbalife (HLF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: Callaway Golf, Herbalife, IAC/InterActiveCorp, Inogen and Salesforce.com
by Zacks Equity Research
Zacks.com featured highlights include: Callaway Golf, Herbalife, IAC/InterActiveCorp, Inogen and Salesforce.com
Bet On 5 Stock Likely to Beat Earnings Estimates
by Sanghamitra Saha
These top-ranked stocks are likely to beat on bottom line in their next releases.
Zacks.com highlights: WillScot, Primerica, Bovie Medical, Shenandoah Telecommunications and Herbalife Nutrition
by Zacks Equity Research
Zacks.com highlights: WillScot, Primerica, Bovie Medical, Shenandoah Telecommunications and Herbalife Nutrition
Snap Up These 5 Stocks on New Analyst Coverage
by Zacks Equity Research
Increased analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.
Direct Selling Strategy Helps Herbalife Rally 44% in a Year
by Zacks Equity Research
Herbalife (HLF) gains from focus on seed-to-feed strategy and solid investments to support direct selling. However, adverse currency movements weigh on its sales view.
Rite Aid (RAD) Posts In-Line Q2 Loss, Tops Sales, Alters Board
by Zacks Equity Research
Rite Aid's (RAD) second-quarter fiscal 2019 loss per share matches estimates while revenues beat. The company reshuffles its board and governance in response to the failed Albertsons merger.
4 Reasons Why You Should Buy Herbalife Post Q2 Earnings
by Zacks Equity Research
Herbalife (HLF) continues with its volume growth trend in the second quarter, which also marks the company's highest ever quarterly volume figure.
Herbalife (HLF) Down 1.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Herbalife (HLF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Pharmacies and Drug Stores Stock Outlook: Prospects Bright
by Zacks Equity Research
Amazon's entry into drug distribution is expected be a game changer but the immediate implications will be limited, given that the healthcare space is highly complex and regulated.
How Will Rite Aid Be Impacted by Albertsons Deal Termination?
by Zacks Equity Research
Rite Aid (RAD) and Albertsons mutually terminate their pending merger deal. Currently, Rite Aid is on track to leverage on its growth strategies as a standalone company.
Rite Aid Stock Falls on FY19 View Cut Ahead of Merger Vote
by Zacks Equity Research
Rite Aid (RAD) lowers fiscal 2019 guidance as the generic drug purchasing efficiencies fall below expectations. Rite Aid shareholders are likely to vote for the Albertsons merger on Aug 9.
3 Nutritional Stocks to Improve Your Portfolio's Health
by Radek Gralak
Prioritizing health and fitness isn't just the latest trend anymore. Today, it is a crucial part of many people's lives.Of course, companies that solely specialize in nutritional products and services have benefited greatly. Here's a look at 3 of them!
Herbalife (HLF) Stock Gains on Robust Q2 Earnings & Outlook
by Zacks Equity Research
Herbalife's (HLF) top and bottom lines improve year over year in Q2. Further, the company records its highest ever quarterly volume this time.
Will U.S. Volume Growth Aid Herbalife (HLF) in Q2 Earnings?
by Zacks Equity Research
Herbalife's (HLF) second-quarter 2018 results are likely to gain from U.S. volume growth and focus on strategies. However, gross margin weakness and dismal trends in China are concerns.
Zacks Investment Ideas feature highlights: Herbalife, Questcor and Tesla
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Herbalife, Questcor and Tesla
The Short Playbook on TSLA, HLF and QCOR
by Brian Bolan
A look at a common theme on three battleground stocks where shorts have been crushed.
Rite Aid (RAD) Reports Q1 Loss, Stock Up on Revenue Beat
by Zacks Equity Research
Rite Aid (RAD) reports first-quarter fiscal 2019 results, with the bottom line lagging estimates. However, the stock is witnessing increased momentum from the pending merger with Albertsons.
Will Herbalife (HLF) Stock Continue With Its Solid Bull Run?
by Zacks Equity Research
Herbalife (HLF) expects its solid growth trends to continue in the second quarter and U.S. volumes to be higher than expected throughout the year.
Walgreens Boots (WBA) in Focus: Stock Moves 5.3% Higher
by Zacks Equity Research
Walgreens Boots (WBA) was a big mover last session, as the company saw its shares rise more than 5% on the day amid huge volumes.
The Zacks Analyst Blog Highlights: Urban Outfitters, Insight Enterprises, Tilly's, Herbalife Nutrition and Tesco
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Urban Outfitters, Insight Enterprises, Tilly's, Herbalife Nutrition and Tesco
U.S. Retail Sales Log the Best Gain in 6 Months: 5 Picks
by Sreya Bhowmick
U.S. retails sales were solid in May, as Americans are spending more on higher wage rates and lower taxes. Investment in retailing stocks seems sensible against this backdrop.
Sonic (SONC) Hits a 52-Week High, Can the Run Continue?
by Zacks Equity Research
Sonic Corp. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for SONC for clues.